Perrigo Company ( (PRGO) ) has released its Q2 earnings. Here is a breakdown of the information Perrigo Company presented to its investors.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Perrigo Company plc is a leading provider of consumer self-care products, primarily operating in North America and Europe, known for its over-the-counter solutions that offer accessibility and choice across various price points and dosage forms. In its second quarter of 2025, Perrigo reported a slight decrease in net sales by 0.9% year-over-year, reaching $1.06 billion, impacted by divestitures and exited products despite favorable currency translation. The company saw improvements in reported operating income, which rose to $45 million from a loss in the previous year, and adjusted EPS increased by 7.5% to $0.57, driven by lower interest expenses. Key performance metrics highlighted a mixed performance across segments, with Consumer Self-Care International seeing a slight increase in net sales, while Consumer Self-Care Americas experienced a decline. The company continues to advance its ‘Three-S’ strategic plan, focusing on stabilizing, streamlining, and strengthening its operations, with a notable agreement to sell its Dermacosmetics business. Looking forward, Perrigo reaffirms its full-year 2025 financial targets, anticipating challenges in the infant formula sector and market consumption trends but remains optimistic about its ability to achieve sustainable growth and shareholder value through strategic initiatives and operational efficiencies.